SPACs Have Lost Their Allure. Time To Buy-The-Dip On The SPAK ETF?

 | May 25, 2021 05:16

Investing in special purpose acquisition companies (SPACs), does not feel as glamorous lately. 2020 will possibly be remembered as the year when investors’ risk appetite for SPACs hit a high.

Yet the picture in 2021 is different, as many of these businesses are off their all-time-highs (ATHs). We previously discussed the basics of going public with a SPAC reverse-merger. Today, we’ll revise the topic to see if an exchange-traded fund (ETF) in the SPAC space could be appropriate investment at this point.

Going Public Via SPACs/h2

Most companies go public through an initial public offering (IPO). SPACs provide an alternative, usually a faster method for private companies to become listed on a stock exchange.

SPACs are blank check companies with funds sitting in escrow until they announce a reverse-merger with a private company. Most of these SPACs initially trade around $10.

As soon as the rumour mill concerning a potential acquisition candidate gets going, the share price usually shoots up. Upon the completion of the merger, fundamental metrics of the new entity become important. Investors understandably want to know whether the company will be able to generate revenue, and preferably profits that create long-term shareholder value.

2020 saw a total of 248 SPACs completed. Within the first five months of 2021, we already have 325 . Several of these recent SPACs include:

  • Adapthealth Corp (NASDAQ:AHCO)—down 33% year-to-date (YTD);
  • Apex Technology (NASDAQ:APXT)—down 32% YTD;
  • Betterware De Mexico (NASDAQ:BWMX)—up 25% YTD;
  • Clover Health Investments (NASDAQ:CLOV)—down 59% YTD;
  • Fastly (NYSE:FSLY)—down 49% YTD;
  • Luminar Technologies (NASDAQ:LAZR)—down 37% YTD;
  • Lordstown Motors Corp (NASDAQ:RIDE)—down 52% YTD;
  • Open Lending(NASDAQ:LPRO)—up 3% YTD;
  • Repay (NASDAQ:RPAY)—down 14% YTD;
  • Skillz (NYSE:SKLZ)—down 24% YTD;
  • Stem (NYSE:STEM)— up 8% YTD.

As the returns above show, the year has not been good to investors in most SPACs and many of these newly-merged companies have come off their recent record high prices.

Against that background, let’s see if investors could consider buying an ETF to invest in companies that have gone public in recent months.

1. Defiance Next Gen SPAC Derived ETF/h2
  • Current Price: $24.46
  • 52-Week Range: $22.10 - $35.08
  • Expense Ratio: 0.45% per year
Get The App
Join the millions of people who stay on top of global financial markets with Investing.com.
Download Now

The Defiance Next Gen SPAC Derived ETF (NYSE:SPAK) has 211 holdings. It tracks the Indxx SPAC & NextGen IPO index, which provides exposure to newly listed SPACs, ex-warrants, and IPOs of the preceding 36 months. The fund is rebalanced quarterly.